- Home
- DTCK vs AKTX Comparison
DTCK vs AKTX Comparison
Compare DTCK & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTCK
- AKTX
- Stock Information
- Founded
- DTCK 1999
- AKTX N/A
- Country
- DTCK Singapore
- AKTX United States
- Employees
- DTCK N/A
- AKTX N/A
- Industry
- DTCK Farming/Seeds/Milling
- AKTX Biotechnology: Pharmaceutical Preparations
- Sector
- DTCK Industrials
- AKTX Health Care
- Exchange
- DTCK Nasdaq
- AKTX Nasdaq
- Market Cap
- DTCK 25.7M
- AKTX 24.5M
- IPO Year
- DTCK 2023
- AKTX N/A
- Fundamental
- Price
- DTCK $0.69
- AKTX $1.09
- Analyst Decision
- DTCK
- AKTX
- Analyst Count
- DTCK 0
- AKTX 0
- Target Price
- DTCK N/A
- AKTX N/A
- AVG Volume (30 Days)
- DTCK 31.9K
- AKTX 28.1K
- Earning Date
- DTCK 11-13-2024
- AKTX 05-15-2025
- Dividend Yield
- DTCK N/A
- AKTX N/A
- EPS Growth
- DTCK N/A
- AKTX N/A
- EPS
- DTCK 0.02
- AKTX N/A
- Revenue
- DTCK $159,836,000.00
- AKTX N/A
- Revenue This Year
- DTCK N/A
- AKTX N/A
- Revenue Next Year
- DTCK N/A
- AKTX N/A
- P/E Ratio
- DTCK $39.69
- AKTX N/A
- Revenue Growth
- DTCK N/A
- AKTX N/A
- 52 Week Low
- DTCK $0.75
- AKTX $0.85
- 52 Week High
- DTCK $1.73
- AKTX $4.40
- Technical
- Relative Strength Index (RSI)
- DTCK 31.17
- AKTX 50.71
- Support Level
- DTCK $0.75
- AKTX $1.26
- Resistance Level
- DTCK $1.10
- AKTX $1.28
- Average True Range (ATR)
- DTCK 0.05
- AKTX 0.14
- MACD
- DTCK -0.02
- AKTX -0.02
- Stochastic Oscillator
- DTCK 4.90
- AKTX 23.94
About DTCK Davis Commodities Limited
Davis Commodities Ltd is an agricultural commodity trading company based in Singapore which specializes in trading of three main categories of agricultural commodities namely sugar, rice, and oil and fat products. It distributes agricultural commodities to various markets, including Asia, Africa and the Middle East. The company also provides customers of commodity offerings with complementary, ancillary services such as warehouse handling and storage and logistics services. The Company operates across four main segments: the sale of sugar, rice, oil and fat products, and others. Among these, the sale of sugar stands out as the primary revenue generator, contributing significantly to the company's overall income.
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).